Who is sponsoring NCT02478775?

NCT02478775 is sponsored by University of Colorado, Denver.

What condition does NCT02478775 study?

NCT02478775 studies Obesity, Fertility.

What drugs are being tested in NCT02478775?

Interventions: Degarelix (GnRH antagonist), recombinant FSH, Cetrorelix.

What is the status of NCT02478775?

NCT02478775 is currently COMPLETED.

Last reviewed 2024-05-10 · How we verify

Dysregulation of Follicle Stimulating Hormone (FSH) in Obesity: Functional and Statistical Analysis

NCT02478775 NA COMPLETED Results posted

Excess maternal weight, especially obesity, influences almost every aspect of fertility, from conception to problems during pregnancy. The investigators will use novel statistical methods to clarify the hormonal changes behind reproductive health conditions. A better understanding of reproductive hormonal changes in obese women may offer a way to identify new treatments.

Details

Lead sponsor	University of Colorado, Denver
Phase	NA
Status	COMPLETED
Enrolment	99
Start date	2015-07
Completion	2021-06-30

Conditions

Obesity
Fertility

Interventions

Degarelix (GnRH antagonist)
recombinant FSH
Cetrorelix

Primary outcomes

Difference Between Peak Inhibin B — Every 10 minutes over 2 10-hour frequent blood sampling sessions.
This is defined as the maximum hormone value during Day 1 of the study subtracted from the maximum hormone value during Day 2.

Countries

United States